Search research articles
Contact Us
Filters
Showing results (81-90 of 100) with videos related to
Page
of 10
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 1, 2024
Liver stiffness predicts progression to liver-related events in patients with chronic liver disease - A cohort study of 14 414 patients
Hannes Hegmar, Axel Wester, Soo Aleman, et al.
Plos One
|
April 5, 2014
A novel fibrosis index comprising a non-cholesterol sterol accurately predicts HCV-related liver cirrhosis
Magdalena Ydreborg, Vera Lisovskaja, Martin Lagging, et al.
Plos One
|
May 12, 2016
Randomized Trial Evaluating the Impact of Ribavirin Mono-Therapy and Double Dosing on Viral Kinetics, Ribavirin Pharmacokinetics and Anemia in Hepatitis C Virus Genotype 1 Infection
Jesper Waldenström, Johan Westin, Kristina Nyström, et al.
Genome Biology
|
June 14, 2021
Leveraging breeding programs and genomic data in Norway spruce (Picea abies L. Karst) for GWAS analysis
Zhi-Qiang Chen, Yanjun Zan, Pascal Milesi, et al.
Hepatology (Baltimore, Md.)
|
February 27, 2010
Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C
Galia Askarieh, Asa Alsiö, Paolo Pugnale, et al.
The New Phytologist
|
September 12, 2022
Teasing apart the joint effect of demography and natural selection in the birth of a contact zone
Lili Li, Pascal Milesi, Mathieu Tiret, et al.
Plos One
|
June 2, 2012
Impact of obesity on the bioavailability of peginterferon-α2a and ribavirin and treatment outcome for chronic hepatitis C genotype 2 or 3
Åsa Alsiö, Karolina Rembeck, Galia Askarieh, et al.
Hepatology (Baltimore, Md.)
|
February 13, 2014
Variants of the inosine triphosphate pyrophosphatase gene are associated with reduced relapse risk following treatment for HCV genotype 2/3
Karolina Rembeck, Jesper Waldenström, Kristoffer Hellstrand, et al.
BMC Medical Genetics
|
September 18, 2012
PNPLA 3 I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection
Karolina Rembeck, Cristina Maglio, Martin Lagging, et al.
Journal of Hepatology
|
August 15, 2006
Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: a randomized phase II trial
Hans Orlent, Bettina E Hansen, Marc Willems, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 100) with videos related to
Sort By:
Page
of 10
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 1, 2024
Liver stiffness predicts progression to liver-related events in patients with chronic liver disease - A cohort study of 14 414 patients
Hannes Hegmar, Axel Wester, Soo Aleman, et al.
Plos One
|
April 5, 2014
A novel fibrosis index comprising a non-cholesterol sterol accurately predicts HCV-related liver cirrhosis
Magdalena Ydreborg, Vera Lisovskaja, Martin Lagging, et al.
Plos One
|
May 12, 2016
Randomized Trial Evaluating the Impact of Ribavirin Mono-Therapy and Double Dosing on Viral Kinetics, Ribavirin Pharmacokinetics and Anemia in Hepatitis C Virus Genotype 1 Infection
Jesper Waldenström, Johan Westin, Kristina Nyström, et al.
Genome Biology
|
June 14, 2021
Leveraging breeding programs and genomic data in Norway spruce (Picea abies L. Karst) for GWAS analysis
Zhi-Qiang Chen, Yanjun Zan, Pascal Milesi, et al.
Hepatology (Baltimore, Md.)
|
February 27, 2010
Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C
Galia Askarieh, Asa Alsiö, Paolo Pugnale, et al.
The New Phytologist
|
September 12, 2022
Teasing apart the joint effect of demography and natural selection in the birth of a contact zone
Lili Li, Pascal Milesi, Mathieu Tiret, et al.
Plos One
|
June 2, 2012
Impact of obesity on the bioavailability of peginterferon-α2a and ribavirin and treatment outcome for chronic hepatitis C genotype 2 or 3
Åsa Alsiö, Karolina Rembeck, Galia Askarieh, et al.
Hepatology (Baltimore, Md.)
|
February 13, 2014
Variants of the inosine triphosphate pyrophosphatase gene are associated with reduced relapse risk following treatment for HCV genotype 2/3
Karolina Rembeck, Jesper Waldenström, Kristoffer Hellstrand, et al.
BMC Medical Genetics
|
September 18, 2012
PNPLA 3 I148M genetic variant associates with insulin resistance and baseline viral load in HCV genotype 2 but not in genotype 3 infection
Karolina Rembeck, Cristina Maglio, Martin Lagging, et al.
Journal of Hepatology
|
August 15, 2006
Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: a randomized phase II trial
Hans Orlent, Bettina E Hansen, Marc Willems, et al.
Page
of 10